Pier Giovanni Baraldi
Corporate Officer/Principal chez University of Ferrara
Profil
Pier Giovanni Baraldi is the founder of PharmEste SRL, which was founded in 2003.
Currently, he holds a position as a Professor at the University of Ferrara.
Postes actifs de Pier Giovanni Baraldi
| Sociétés | Poste | Début |
|---|---|---|
| University of Ferrara | Corporate Officer/Principal | 07/09/2009 |
Anciens postes connus de Pier Giovanni Baraldi
| Sociétés | Poste | Fin |
|---|---|---|
PharmEste SRL
 PharmEste SRL Miscellaneous Commercial ServicesCommercial Services PharmEste is a private biopharmaceutical company based on a unique Transient Receptor Potential (TRPs) ion channel technology platform that brings together strong expertise on TRPs area and industrial competences in research & development process applied to small molecule therapeutics. The company mission is to play a leading role in the discovery and development of fully proprietary high affinity and selective TRP channel therapeutics for the treatment of neuropathic pain, overactive bladder and other TRP-mediated diseases. PharmEste is developing PHE377, a selective TRPV1 antagonist for the treatment of neuropathic pain. PHE377 has successfully completed the preclinical phase showing a high safety profile. Phase I clinical development is ongoing and PoC studies (Phase IIa) in patients are planned in two major clinical indications such as painful diabetic neuropathy and post herpetic neuralgia. Second generation of TRPV1 antagonists are at final lead optimization stage and a discovery program on TRPs antagonists is ongoing in order to identify new drug candidates for the treatment of other TRP-mediated diseases. PharmEste is located both in Ferrara and Milan (Italy), it is managed by an industrial and multidisciplinary team with many years of experience and account of 12 people. The Company is supported by an outstanding international advisory board with scientific, clinical and industrial competences. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
PharmEste SRL
PharmEste SRL Miscellaneous Commercial ServicesCommercial Services PharmEste is a private biopharmaceutical company based on a unique Transient Receptor Potential (TRPs) ion channel technology platform that brings together strong expertise on TRPs area and industrial competences in research & development process applied to small molecule therapeutics. The company mission is to play a leading role in the discovery and development of fully proprietary high affinity and selective TRP channel therapeutics for the treatment of neuropathic pain, overactive bladder and other TRP-mediated diseases. PharmEste is developing PHE377, a selective TRPV1 antagonist for the treatment of neuropathic pain. PHE377 has successfully completed the preclinical phase showing a high safety profile. Phase I clinical development is ongoing and PoC studies (Phase IIa) in patients are planned in two major clinical indications such as painful diabetic neuropathy and post herpetic neuralgia. Second generation of TRPV1 antagonists are at final lead optimization stage and a discovery program on TRPs antagonists is ongoing in order to identify new drug candidates for the treatment of other TRP-mediated diseases. PharmEste is located both in Ferrara and Milan (Italy), it is managed by an industrial and multidisciplinary team with many years of experience and account of 12 people. The Company is supported by an outstanding international advisory board with scientific, clinical and industrial competences. | Commercial Services |
